DK535988D0 - IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE - Google Patents

IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE

Info

Publication number
DK535988D0
DK535988D0 DK535988A DK535988A DK535988D0 DK 535988 D0 DK535988 D0 DK 535988D0 DK 535988 A DK535988 A DK 535988A DK 535988 A DK535988 A DK 535988A DK 535988 D0 DK535988 D0 DK 535988D0
Authority
DK
Denmark
Prior art keywords
methods
immunosuppressive peptides
immunosuppressive
peptides
Prior art date
Application number
DK535988A
Other languages
Danish (da)
Other versions
DK535988A (en
Inventor
William S Kloetzer
Robert B Naso
John F Warner
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK535988D0 publication Critical patent/DK535988D0/en
Publication of DK535988A publication Critical patent/DK535988A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK535988A 1987-01-28 1988-09-27 IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE DK535988A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US750987A 1987-01-28 1987-01-28
PCT/US1988/000176 WO1988005783A1 (en) 1987-01-28 1988-01-25 Immunosuppressive peptides and methods of use

Publications (2)

Publication Number Publication Date
DK535988D0 true DK535988D0 (en) 1988-09-27
DK535988A DK535988A (en) 1988-11-25

Family

ID=21726617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK535988A DK535988A (en) 1987-01-28 1988-09-27 IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE

Country Status (6)

Country Link
EP (1) EP0300031A4 (en)
JP (1) JPH01501939A (en)
KR (1) KR890700602A (en)
AU (1) AU1366088A (en)
DK (1) DK535988A (en)
WO (1) WO1988005783A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
SE8705197D0 (en) * 1987-12-30 1987-12-30 Jonas Blomberg NEW PEPTIDES, TWO DIAGNOSTIC METHODS USING THE PEPTIDES AND A MEDICATION BASED ON THE PEPTIDES
IE74875B1 (en) * 1988-12-13 1997-08-13 Harvard College Prototype FeLV isolates for use in disease models and vaccines
US5268455A (en) * 1989-05-25 1993-12-07 Genentech, Inc. Process for making biologically active polypeptides based on transforming growth factor-βsequences
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
JP2807287B2 (en) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 Peptides and their uses
US5567805A (en) * 1990-03-09 1996-10-22 Administrators Of The Tulane Educational Fund The cellular receptor for the CS3 peptide of human immunodeficiency virus
FR2677654B1 (en) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT.
JPH07506810A (en) * 1992-02-10 1995-07-27 デューク・ユニバーシティ Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes that are self-antigens
SE9202318L (en) * 1992-08-10 1994-02-11 Replico Medical Ab New peptides, diagnostic antigens, their use, vaccines and drugs
JP4113580B2 (en) 1994-02-07 2008-07-09 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for reducing or removing endotoxin
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
SE9403526D0 (en) 1994-10-14 1994-10-14 Astra Ab New Peptides
DZ1964A1 (en) * 1995-01-13 2002-10-15 Nika Health Products Ltd New applications of a lysozyme dimer.
SE9501067D0 (en) * 1995-03-24 1995-03-24 Astra Ab New peptides
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
AU2417597A (en) * 1996-04-12 1997-11-07 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory ef fects
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
SE9603461D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
IT1307826B1 (en) 1999-12-16 2001-11-19 Dipartimento Di Medicina Speri DIAGNOSTIC METHOD FOR THE RECOGNITION OF NORMAL ELEUCEMIC MYELOID CELLS, LIGANDS USED IN THAT METHOD AND FORMULATIONS FOR USE
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
EP1648926B1 (en) 2003-05-02 2013-07-03 Centre National De La Recherche Scientifique (Cnrs) Glut-1 as a receptor for htlv envelopes and its uses
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CN102326079B (en) 2009-01-09 2015-04-15 国家科研中心 New receptor binding ligands, their use in the detection of cells with biological interest

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262014A (en) * 1983-01-07 1989-09-26 Mitsuaki Yoshida Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
GB8301928D0 (en) * 1983-01-24 1983-02-23 Nicholson B H Process for producing polypeptides
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
ATE116006T1 (en) * 1985-04-29 1995-01-15 Genetic Systems Corp SYNTHETIC ANTIGENS FOR DETECTING AIDS.
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
EP0300031A1 (en) 1989-01-25
DK535988A (en) 1988-11-25
WO1988005783A1 (en) 1988-08-11
AU1366088A (en) 1988-08-24
JPH01501939A (en) 1989-07-06
KR890700602A (en) 1989-04-26
EP0300031A4 (en) 1990-05-14

Similar Documents

Publication Publication Date Title
DK535988A (en) IMMUNOSUPPRESSIVE PEPTIDES AND METHODS OF USE
DK80591D0 (en) DIRECTORY AND PROCEDURE
NO172904C (en) ALLOYS AND USE OF THESE
DK47285D0 (en) PURE-INHIBITING PEPTIDES AND THEIR USE thereof
DK299087D0 (en) PROTEINS AND DERIVATIVES THEREOF
DK359686A (en) LYOFILIZED EMULSING AGENTS AND PROCEDURE
DK183488A (en) FOREIGN DERIVATIVES AND USE THEREOF
DK413187A (en) SEMICARBAZONS AND THIOSEMICARBAZONS
DK196088A (en) RECOMBINANT HTLV-III PROTEIN AND ITS USE
DK240689D0 (en) CONTAINING COPOLYMERIZATES AND APPLICATION THEREOF
DK675688A (en) GRISOOL ACID MONOESTERS AND THE PROCEDURE AND APPLICATION OF THEREOF
NO179410C (en) Analogous methods for the preparation of therapeutically active monobenzophyrins and their use
IS3269A7 (en) New peptides and their use
DK479989A (en) CARBON HYDRADEMULATION AND USE THEREOF
SE8702336D0 (en) COMBINED GAS AND ANGTURBINE
DK90087D0 (en) SCAFFILIATE AND SCANDBOOK THEREOF
DK627389D0 (en) PROTEINS AND DERIVATIVES THEREOF
DK363786A (en) HYDROQUINOLINES AND USE THEREOF
DK577388D0 (en) HUMANT INTERLEUKIN -3 AND MUTEINES THEREOF
DK396988A (en) PEPTIDES AND MANUFACTURING AND USING THEREOF
DK732788A (en) MYCOBACTERIAL RECOMBINANTS AND PEPTIDES
DK125786D0 (en) PEPTIDES AND PREPARATION THEREOF
DK94288D0 (en) SCAFFILIATE AND SCANDBOOK THEREOF
DK405788D0 (en) SPEECH AND SPEECH BLOCK THEREOF
DK238585D0 (en) PEPTIDES AND PREPARATION THEREOF

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment